Intensity Therapeutics, Inc. (INTS) NASDAQ

0.46

-0.0302(-6.22%)

Updated at November 07 04:00PM

Currency In USD

Valuation

Market Cap24.48M
Enterprise Value22.02M
P/E Ratio-1.67
PEG Ratio-0.07
Price/Sales Ratio894.06
Price/Book Ratio2.71
Enterprise/Revenue604.52
Enterprise/EBITDA-1.23

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-489
Operating Margin-501.46

Management Effectiveness

Return On Assets-1.22
Return On Equity-3.71

Income Statement

Revenue0
Revenue/Share0
Gross Profit-25,000
EBITDA-16.24M
Net Income-16.27M
Diluted EPS-1.17

Balance Sheet

Total Cash7.07M
Total Cash/Share0.16
Total Debt118,000
Total Debt/Equity0.02
Current Ratio3.6
Book Value Per Share0.17

Price History

52-Week Change-86.21
52-Week High3.4
52-Week Low0.19
Moving Average 50 Days0.32
Moving Average 200 Days0.9

Statistics

Average Volume30.37M
Shares Outstanding47.15M
% Held by Institutions10.49

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A